Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Starting soon Observational

Perioperative Smoking Cessation in Elderly Chinese Undergoing Spinal Fusion

NCT06578611 · tracked via the Priya Life Science China tracker
Phase
Observational
Started
2024-09
Last updated
2024-08-29

Condition(s) studied

Spinal Fusion

Investigational drug(s) / intervention(s)

Enhanced recovery after surgery

Enhanced recovery after surgery: Recommended pre-, intra-, and post-operative care interventions in the enhanced recovery after surgery.

Study summary

As China's society ages faster, the number of elderly patients undergoing spinal fusion surgery will gradually increase. Since elderly patients are at higher risk of postoperative complications than younger patients, minimizing complications after spinal fusion becomes a priority in postoperative rehabilitation. The purpose of this prospective cohort study is to develop an enhanced recovery after surgery program including individualized perioperative smoking cessation strategies in Chinese elderly undergoing spinal fusion.

Eligibility

Sex
ALL
Min age
65 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. Patients aged 65 years old or more; 2. Patients who plan to undergo spinal fusion with ERAS program; 3. Patients who agreed to participate in this study. Exclusion Criteria: 1. Patients who cannot understand the study content or have difficulty communicating; 2. Patients with a history of spinal fusion surgery; 3. Patients with spinal fractures, spinal tumor, or spinal infections; 4. Patients with congenital spinal deformity; 5. Patients who were unable to complete at least 6 months of follow-up; 6. Patients with incomplete clinical information.

Primary outcome measure(s)

  • Incidence of any complications — From the date of surgery until 6 months after surgery or the date of death from any cause, whichever come first.
    Any major or minor complications occurs during this study will be reported.

Trial sites (1)

FacilityCityRegionStatus
The Second Hospital of Shandong University Jinan Shandong
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06578611 on ClinicalTrials.gov ↗ ← All trials in China